Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation.
Campbell HM, Quick AP, Abu-Taha I, Chiang DY, Kramm CF, Word TA, Brandenburg S, Hulsurkar M, Alsina KM, Liu HB, Martin B, Uhlenkamp D, Moore OM, Lahiri SK, Corradini E, Kamler M, Heck AJR, Lehnart SE, Dobrev D, Wehrens XHT. Campbell HM, et al. Among authors: moore om. Circulation. 2020 Sep 22;142(12):1159-1172. doi: 10.1161/CIRCULATIONAHA.120.045791. Epub 2020 Jul 20. Circulation. 2020. PMID: 32683896 Free PMC article.
Variant-specific therapy for long QT syndrome type 3.
Moore OM, Dorn LE, Wehrens XHT. Moore OM, et al. Heart Rhythm. 2023 May;20(5):718-719. doi: 10.1016/j.hrthm.2023.02.013. Epub 2023 Feb 15. Heart Rhythm. 2023. PMID: 36806575 Free PMC article. No abstract available.
Genome Editing and Cardiac Arrhythmias.
Moore OM, Ho KS, Copeland JS, Parthasarathy V, Wehrens XHT. Moore OM, et al. Cells. 2023 May 11;12(10):1363. doi: 10.3390/cells12101363. Cells. 2023. PMID: 37408197 Free PMC article. Review.
Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation.
Song J, Navarro-Garcia JA, Wu J, Saljic A, Abu-Taha I, Li L, Lahiri SK, Keefe JA, Aguilar-Sanchez Y, Moore OM, Yuan Y, Wang X, Kamler M, Mitch WE, Ruiz-Hurtado G, Hu Z, Thomas SS, Dobrev D, Wehrens XH, Li N. Song J, et al. Among authors: moore om. J Clin Invest. 2023 Oct 2;133(19):e167517. doi: 10.1172/JCI167517. J Clin Invest. 2023. PMID: 37581942 Free PMC article.
Long-term efficacy and safety of cardiac genome editing for catecholaminergic polymorphic ventricular tachycardia.
Moore OM, Aguilar-Sanchez Y, Lahiri SK, Hulsurkar MM, Alberto Navarro-Garcia J, Word TA, Keefe JA, Barazi D, Munivez EM, Moore CT, Parthasarathy V, Davidson J, Lagor WR, Park SH, Bao G, Miyake CY, Wehrens XHT. Moore OM, et al. J Cardiovasc Aging. 2024 Jan;4(1):8. doi: 10.20517/jca.2023.42. Epub 2024 Jan 4. J Cardiovasc Aging. 2024. PMID: 38464671
Targeting calpain-2-mediated junctophilin-2 cleavage delays heart failure progression following myocardial infarction.
Lahiri SK, Lu J, Aguilar-Sanchez Y, Li H, Moreira LM, Hulsurkar MM, Mendoza A, Turkieltaub Paredes MR, Navarro-Garcia JA, Munivez E, Horist B, Moore OM, Weninger G, Brandenburg S, Lenz C, Lehnart SE, Sayeed R, Krasopoulos G, Srivastava V, Zhang L, Karch JM, Reilly S, Wehrens XHT. Lahiri SK, et al. Among authors: moore om. J Mol Cell Cardiol. 2024 Sep;194:85-95. doi: 10.1016/j.yjmcc.2024.06.011. Epub 2024 Jul 2. J Mol Cell Cardiol. 2024. PMID: 38960317
13 results